Investigation of a novel, heritable bleeding diathesis of thoroughbred horses and development of a screening assay

Journal of Veterinary Internal Medicine

Volumn 20, Issue 6, 2006, Pages 1450-1456

  Norris, Jeffrey W ^a   Pratt, Suzanne M ^b   Auh, Joong Hyuck ^a   Wilson, Sandra J ^a   Clutter, Dana ^a   Magdesian, K Gary ^a   Ferraro, Gregory L ^a   Tablin, Fern ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b PURDUE UNIVERSITY   (United States)

Author keywords

Annexin V binding; Fibrinogen binding; Horse; Inherited coagulopathy; Platelet aggregation; Prothrombinase

Indexed keywords

FIBRINOGEN; LIPOCORTIN 5; PHOSPHATIDYLSERINE; THROMBIN;

ANIMAL; ANIMAL DISEASE; ARTICLE; BIOSYNTHESIS; BLEEDING DISORDER; BLOOD; CASE CONTROL STUDY; CHEMISTRY; ENZYME ACTIVATION; ENZYMOLOGY; FEMALE; FLOW CYTOMETRY; GENETICS; HORSE; HORSE DISEASE; METABOLISM; THROMBOCYTE;

ANIMALS; ANNEXIN A5; BLOOD PLATELETS; CASE-CONTROL STUDIES; ENZYME ACTIVATION; FEMALE; FIBRINOGEN; FLOW CYTOMETRY; HEMORRHAGIC DISORDERS; HORSE DISEASES; HORSES; PHOSPHATIDYLSERINES; THROMBIN;

ANIMALIA; EQUIDAE; EQUUS CABALLUS;

EID: 33845700037     PISSN: 08916640     EISSN: None     Source Type: Journal    
DOI: 10.1892/0891-6640(2006)20[1450:IOANHB]2.0.CO;2     Document Type: Article

References (35)

1. Platt H. Sudden and unexpected deaths in horses: A review of 69 cases. Br Vet J 1982;138:417-429.
2. Gelberg HB, Zachary JF, Everitt JI, et al. Sudden death in training and racing Thoroughbred horses. J Amer Vet Assoc 1985;187:1354-1356.
3. Brown CM, Kaneene JB, Taylor RF. Sudden and unexpected death in horses and ponies: An analysis of 200 cases. Equine Vet J 1988;20:99-103.
4. Gunson DE, Sweeney CR, Soma LR. Sudden death attributable to exercise-induced pulmonary hemorrhage in racehorses: 9 cases (1981-1983). J Amer Vet Assoc 1988;193:102-106.
5. Johnson BJ, Stover SM, Daft BM, et al. Causes of death in racehorses over a 2 year period. Equine Vet J 1994;26:327-330.
6. Trim CM, Eaton SA, Parks AH. Severe nasal hemorrhage in an anesthetized horse. J Amer Vet Assoc 1997;210:1324-1327.
7. Birks EK, Durando MM, McBride S. Exercise-induced pulmonary hemorrhage. Vet Clin Equine 2003;19:87-100.
8. Johnstone IB, Crane VL, Whiting T. Hemostatic studies in racing Standardbred horses with exercise-induced pulmonary hemorrhage. Hemostatic parameters at rest and after moderate exercise. Can J Vet Res 1991;55:101-106.
9. Bayly WM, Meyers KM, Keck MT, et al. Effects of furosemide on exercise-induced alterations in haemostasis in Thoroughbred horse exhibiting post-exercise epistaxis. In: Snow DH, Persson SGB, Rose RJ, eds. Equine Exercise Physiology. Cambridge, UK: Burlington Press; 1982:64-70.
10. Bayly WM, Meyers KM, Keck MT, et al. Exercise-induced alterations in haemostasis in Throughbred horses. In: Snow DH, Persson SGB, Rose RJ, eds. Equine Exercise Physiology. Cambridge, UK: Burlington Press; 1982:336-343.
11. Weiss DJ, McClay CB, Smith CM, et al. Platelet function in the racing Thoroughbred: Implication for exercise-induced pulmonary haemorrhage. Vet Clin Pathol 1990;19:35-39.
12. Cattaneo M. Inherited platelet-based bleeding disorders. J Thromb Haemost 2003;1:1628-1636.
13. Weideman H, Schoeman SJ, Jordaan GF. The inheritance of liability to epistaxis in the southern African Thoroughbred. S Afr Vet Assoc 2004;75:158-162.
14. Smith BP. Diseases associated with blood loss or hemostatic dysfunction. In: Large Animal Internal Medicine, 3rd ed. St Louis, MO: Mosby; 2002:1039-1048.
15. Sutherland RJ, Cambridge H, Bolton JR. Functional and morphological studies on blood platelets in a thrombasthenic horse. Aust Vet J 1989;66:366-370.
16. Livesey L, Christopherson P, Hammond A, et al. Platelet dysfunction (Glanzmann's thrombasthenia) in horses. J Vet Intern Med 2005;19:917-919.
17. Christopherson PW, Insalaco TA, van Santen., et al. Characterization of the cDNA encoding αIIb and β3 in normal horses and two horses with Glanzmann thrombasthenia. Vet Pathol 2006;43:78-82.
18. Fry MM, Walker NJ, Blevins GM, et al. Novel platelet function defect in a Thoroughbred filly. J Vet Internal Medicine 2005;19:359-362.
19. Monroe DM, Hoffman M, Roberts HR. Platelets and thrombin generation. Arterioscler Thromb Vasc Biol 2002;22:1381-1389.
20. Shattil SJ, Newman PJ. Integrins: Dynamic scaffolds for adhesion and signaling in platelets. Blood 2004;104:1606-1615.
21. Dachary-Prigent J, Freyssinet JM, Pasquet JM, et al. Annexin V as a probe of aminophospholipid exposure and platelet membrane vesiculation: A flow cytometry study showing a role for free sulfhydryl groups. Blood 1993;81:2554-2565.
22. Kingston JK, Bayly WM, Sellon DC, et al. Measurement of the activation of equine platelets by use of fluorescent-labeled annexin V, anti-human fibrinogen antibody, and anti-human thrombospondin antibody. Am J Vet Res 2002;63:513-519.
23. Baruch D, Hemker HC, Lindhout T. Kinetics of thrombin-induced release and activation of platelet factor V. Eur J Biochem 1986;154:213-218.
24. Tracy PB, Nesheim ME, Mann KG. Coordinate binding of factor Va and factor Xa to the unstimulated platelet. J Biol Chem 1981;256:743-751.
25. Faraday N, Goldschmidt-Clermont P, Dise K, et al. Quantitation of soluble fibrinogen binding to platelets by fluorescence-activated flow cytometry. J Lab Clin Med 1994;123:728-740.
26. Laudano AP, Doolittle RF. Synthetic peptide derivatives that bind to fibrinogen and prevent the polymerization of fibrin monomers. Proc Natl Acad Sci U S A 1978;75:3085-3089.
27. Edson JR, White JG, Krivit W. The enigma of severe factor XI deficiency without haemorrhagic symptoms. Thromb Diath Haemorrh 1967;18:324-348.
28. Sims PJ, Wiedmer T, Esmon CT, et al. Assembly of the platelet prothrombinase complex is linked to vesiculation of the platelet plasma membrane. Studies in Scott syndrome: An isolated defect in platelet procoagulant activity. J Biol Chem 1989;264:17049-17057.
29. Kahr WH, Zheng S, Sheth PM, et al. Platelets from patients with the Quebec platelet disorder contain and secrete abnormal amounts of urokinase-type plasminogen activator. Blood 2001;98:257-265.
30. Hayward CPM, Welch B, Bouchard M, et al. Fibrinogen degradation products in patients with the Quebec platelet disorder. Br J Haematol 1997;97:497-503.
31. Weiss HJ, Lages B, Zheng S, et al. Platelet factor V New York: A defect in factor V distinct from that in factor V Quebec resulting in impaired prothrombinase generation. Am J Hematol 2001;66:130-139.
32. Woulfe D, Jiang H, Morgans A, et al. Detects in secretion, aggregation, and thrombus formation in platelets from mice lacking Akt2. J Clin Invest 2004;113:441-450.
33. Chen J, De S, Damron DS, et al. Impaired platelet responses to thrombin and collagen in Akt-1-deficient mice. Blood 2004;104:1703-1710.
34. Born GVR. Platelets: Functional physiology. In: Biggs R, ed. Human Blood Coagulation, Haemostasis and Thrombosis. London, UK: Blackwell Scientific Publications; 1972:159-175.
35. White JG, Matlack KL, Mundschenk D, et al. Platelet studies in normal and a bleeder horse. In: Kitchen H, Krehbiel JD, eds. Proceedings of First International Symposium on Equine Hematology. Golden, CO: American Association of Equine Practitioners; 1976:209-221.